Keyphrases
Pancreatic β-cell Function
100%
β-Cell Survival
66%
Cellular Mechanisms
58%
Divergent Effects
50%
Adverse Effects
50%
Mitochondrial Dysfunction
50%
Drug Use
50%
Antiviral Drugs
50%
Survival Chances
50%
HIV-1 Reverse Transcriptase
50%
Therapeutic Intervention
50%
Rilpivirine
50%
Intervention Points
50%
Oxidative Stress
50%
Efavirenz
41%
Nucleosides
25%
INS-1E Cells
25%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
25%
Reverse Transcriptase Inhibitors
25%
Type 2 Diabetes Mellitus (T2DM)
25%
Doravirine
16%
Tenofovir Disoproxil Fumarate
16%
Emtricitabine
16%
Insulin
16%
β-cell Function
16%
Damaging Effects
16%
Cell Viability
16%
Type 2 Diabetic
16%
Glucose-regulated Protein 78 (GRP78)
8%
Oxidative Stress Toxicity
8%
Apoptosis-necrosis
8%
Type 2 Diabetes Mellitus Risk
8%
Endoplasmic Reticulum Stress (ER stress)
8%
Mitochondrial ATP Synthase
8%
HIV Patients
8%
Mitochondrial Toxicity
8%
Antiretroviral Therapy
8%
B Cells
8%
Protein Expression
8%
Life-sustaining Treatment
8%
Contrast Effect
8%
MRNA Expression
8%
Induced Apoptosis
8%
Deleterious Effects
8%
Molecular Mechanism
8%
In Silico Docking
8%
AIDS/HIV
8%
Cell Apoptosis
8%
Insulin Release
8%
ROS Generation
8%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
66%
RNA Directed DNA Polymerase
50%
Adverse Event
50%
Rilpivirine
50%
RNA Directed DNA Polymerase Inhibitor
50%
Efavirenz
41%
Non Insulin Dependent Diabetes Mellitus
33%
Nucleoside
25%
Nonnucleoside Reverse Transcriptase Inhibitor
25%
Doravirine
16%
Tenofovir Disoproxil
16%
Cell Viability
16%
Emtricitabine
16%
Diabetes Mellitus
16%
Mitochondrial Toxicity
8%
Necrosis
8%
Adenosine Triphosphate
8%
Synthetase
8%
Insulinoma
8%
Messenger RNA
8%
